Yusuf Yilmaz

Summary

Affiliation: Uludag University
Country: Turkey

Publications

  1. pmc Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Hepat Mon 11:103-6. 2011
  2. doi Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul
    Scand J Clin Lab Invest 71:631-6. 2011
  3. doi Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, Istanbul, Turkey
    Eur J Clin Invest 42:411-8. 2012
  4. doi Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul
    Ann Clin Biochem 47:549-53. 2010
  5. doi Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, 34899 Istanbul, Turkey
    Clin Chim Acta 412:2296-9. 2011
  6. pmc Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Uludag University Medical School, Department of Internal Medicine, Bursa 16059, Turkey
    World J Gastroenterol 13:837-44. 2007
  7. pmc Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?
    Yusuf Yilmaz
    World J Gastroenterol 15:4346-7. 2009
  8. pmc Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, 34662 Altunizade, Istanbul, Turkey
    World J Gastroenterol 15:4387-91. 2009
  9. ncbi Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
    Y Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Aliment Pharmacol Ther 30:1103-9. 2009
  10. doi Serum galectin-3 levels in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, 34899 Istanbul, Turkey
    Clin Biochem 44:955-8. 2011

Collaborators

Detail Information

Publications74

  1. pmc Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Hepat Mon 11:103-6. 2011
    ..The aspartate aminotransferases (AST) to platelet ratio index (APRI) may serve as a noninvasive marker to assess liver fibrosis...
  2. doi Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul
    Scand J Clin Lab Invest 71:631-6. 2011
    ..24; t = -2.146, p < 0.05). Compared with controls, NAFLD patients have a decrease in serum OCN concentrations, which is significantly associated with serum transaminases and the extent of hepatocyte ballooning...
  3. doi Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, Istanbul, Turkey
    Eur J Clin Invest 42:411-8. 2012
    ..However, not all patients with the MS will develop NAFLD and not all patients with NAFLD have the MS. We sought to investigate the differences between patients with biopsy-proven NAFLD with and without the MS...
  4. doi Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul
    Ann Clin Biochem 47:549-53. 2010
    ..We assayed serum levels of AHSG in patients with non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, and examined their association with clinical, biochemical and histological phenotypes...
  5. doi Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, 34899 Istanbul, Turkey
    Clin Chim Acta 412:2296-9. 2011
    ..However, the relationship between serum PEDF and nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, remains unknown...
  6. pmc Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Uludag University Medical School, Department of Internal Medicine, Bursa 16059, Turkey
    World J Gastroenterol 13:837-44. 2007
    ....
  7. pmc Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?
    Yusuf Yilmaz
    World J Gastroenterol 15:4346-7. 2009
    ..Although current biomarkers do not entirely fulfill the many requirements for the identification of patients with NASH, they should not discourage our quest, but remind us that we need to cognize the challenges ahead...
  8. pmc Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, 34662 Altunizade, Istanbul, Turkey
    World J Gastroenterol 15:4387-91. 2009
    ..Our article provides an overview of biomarker discovery and selection in the setting of NAFLD and highlights future directions in the field...
  9. ncbi Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
    Y Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Aliment Pharmacol Ther 30:1103-9. 2009
    ..Biomarkers hold great promise for detecting chronic liver disease without the use of liver biopsy...
  10. doi Serum galectin-3 levels in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, 34899 Istanbul, Turkey
    Clin Biochem 44:955-8. 2011
    ..Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes...
  11. doi Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, 34899 Istanbul, Turkey
    Atherosclerosis 217:125-9. 2011
    ..We therefore evaluated the relation of epicardial fat thickness, serum levels of epicardial fat-related adipokines (chemerin and vaspin), and CFR in patients with NAFLD...
  12. doi Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Clin Chem Lab Med 49:93-7. 2011
    ..We measured serum ZAG in patients with non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, and examined its association with clinical, biochemical, and histological phenotypes...
  13. doi Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Arch Med Res 42:38-43. 2011
    ..We explored the associations of VEGF and sVEGFR-1 concentrations with liver histology in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD)...
  14. doi Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul 34662, Turkey
    Metabolism 59:1327-30. 2010
    ..In addition, microalbuminuria may identify NAFLD patients with higher fibrosis scores...
  15. doi Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Tophanelioglu Cad No 13 15 Altunizade, 34662 Istanbul, Turkey
    Atherosclerosis 211:182-6. 2010
    ..We evaluated the prevalence of impaired CFR in patients with biopsy-proven NAFLD. We also investigated the independent clinical, biochemical, and liver histology predictors of CFR in the setting of NAFLD...
  16. doi Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Eur J Clin Invest 40:887-92. 2010
    ....
  17. doi Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Scand J Gastroenterol 46:91-7. 2011
    ..We assayed circulating levels of these molecules and examined their association with clinical, biochemical, and histological phenotypes in patients with nonalcoholic fatty liver disease (NAFLD)...
  18. doi Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans
    Y Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, Istanbul, Turkey
    Aliment Pharmacol Ther 34:318-23. 2011
    ..The presence of active brown adipose tissue (BAT) has been associated with a reduced risk of obesity in adult humans...
  19. doi Cytokeratins in hepatitis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, 34899 Istanbul, Turkey
    Clin Chim Acta 412:2031-6. 2011
    ..Understanding the mechanisms of hepatitis impact on CK and vice versa is a promising area of research that will positively enhance our understanding of the complexity of acute and chronic inflammatory liver injury...
  20. ncbi Apical ballooning syndrome: a metabolic form of cardiomyopathy?
    Yusuf Yilmaz
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Med Sci Monit 14:HY9-12. 2008
    ..Evidence to support this hypothesis is given and possible therapeutic implications are discussed...
  21. ncbi Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis
    Y Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, 34662 Altunizade, Istanbul, Turkey
    Curr Med Chem 18:725-32. 2011
    ..We will also consider the practical and statistical issues that seem to be limiting the effective integration of biomarkers into clinical development...
  22. ncbi Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey
    Scand J Clin Lab Invest 70:541-6. 2010
    ..Reduced OPG levels are related to insulin resistance. We tested the hypothesis that serum levels of OPG may be associated with nonalcoholic fatty liver disease (NAFLD)...
  23. ncbi Helicobacter pylori: a role in schizophrenia?
    Yusuf Yilmaz
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Med Sci Monit 14:HY13-6. 2008
    ..Evidence in favor of this hypothesis is provided and possible therapeutic implications are discussed...
  24. pmc Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Dis Markers 31:205-10. 2011
    ..We sought to determine whether serum progranulin levels are altered in patients with biopsy-proven NAFLD and if they are associated with their clinical, biochemical, and histological characteristics...
  25. ncbi Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey
    Med Sci Monit 15:HY1-5. 2009
    ..Future research is expected to support the efficacy and tolerability of dipeptidyl peptidase IV modulation in early liver steatosis.<br />..
  26. doi Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity
    Y Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul 34899, Turkey
    J Crohns Colitis 5:402-6. 2011
    ..Soluble receptor for advanced glycation endproducts (sRAGE) has recently emerged as a reliable biomarker of inflammation in numerous RAGE-mediated disorders...
  27. doi Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, 34662, Altunizade, Istanbul, Turkey
    Clin Biochem 42:802-7. 2009
    ..We tested the hypothesis that plasma levels of sRAGE may be associated with non-alcoholic fatty liver disease...
  28. ncbi Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C
    Yusuf Yilmaz
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Med Sci Monit 15:CR189-93. 2009
    ..To shed more light on the rate of hepatocyte loss by apoptosis in chronic liver disease, serum levels of CK18-Asp396 were examined in patients with nonalcoholic steatohepatitis (NASH) and chronic hepatitis C...
  29. doi Acute arsenic self-poisoning for suicidal purpose in a dentist: a case report
    Y Yilmaz
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Hum Exp Toxicol 28:63-5. 2009
    ..He gradually recovered from anemia within 5 months. The patient did not suffer any adverse outcome in spite of having ingesting 4 g of arsenic, approximately 20 times the lethal dose...
  30. doi Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease
    Bilge Aktas
    Department of Internal Medicine, Marmara University School of Medicine, Altunizade, Istanbul 34662, Turkey
    Metabolism 60:544-9. 2011
    ..These findings support further investigation of this novel adipokine in metabolic liver diseases...
  31. doi Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey
    Dig Liver Dis 45:58-62. 2013
    ..In the present study, we sought to investigate whether serum osteopontin concentrations are associated with liver histology in patients with nonalcoholic fatty liver disease...
  32. doi Assessment of endothelial function in patients with nonalcoholic fatty liver disease
    Yasar Colak
    Department of Gastroenterology, Istanbul Medeniyet Universty Medical Faculty, Istanbul Goztepe Education and Research Hospital, 34730, Istanbul, Turkey
    Endocrine 43:100-7. 2013
    ..61 ± 0.11 vs. 0.69 ± 0.37 μmol/L, P = 0.209). Our data suggested that NAFLD is associated with endothelial dysfunction and increased earlier in patients with atherosclerosis compared to control subjects...
  33. doi Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
    Fatih Eren
    Institute of Gastroenterology, Marmara University, Maltepe, 34840, Istanbul, Turkey
    Clin Biochem 45:655-8. 2012
    ....
  34. ncbi Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients
    Mahmut Arabul
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Med Sci Monit 15:CR583-7. 2009
    ..This study investigated the effect of erythropoietin (EPO) therapy on serum levels of prohepcidin, the pro-hormone of hepcidin, in patients with end-stage renal disease (ESRD) undergoing chronic dialysis treatment...
  35. doi Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology
    Yasar Colak
    Department of Gastroenterology, Istanbul Goztepe Education and Research Hospital, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 24:255-61. 2012
    ....
  36. doi Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease
    Tunay Senturk
    Department of Cardiology, Uludag University Medical School, Bursa, Turkey
    Coron Artery Dis 20:494-8. 2009
    ..In this study, serum levels of M30 and M65 were measured in 74 patients with ACS [including 17 cases with unstable angina and 57 patients with acute myocardial infarction (AMI)], 25 patients with stable angina, and 23 controls...
  37. doi Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B
    Fatih Eren
    Institute of Gastroenterology, Marmara University, Istanbul, Turkey, Maltepe, Istanbul 34840, Turkey
    Clin Chim Acta 411:2029-32. 2010
    ..In this study, we sought to determine whether serum M30-antigen levels can serve as a useful biomarker of liver injury in the clinical spectrum of HBV infection...
  38. doi Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back
    Yusuf Yilmaz
    Institute of Gastroenterology, of Medicine, Marmara University, Istanbul, Turkey
    Tumori 99:10-6. 2013
    ..Recent years have witnessed significant advances in our understanding of the mechanisms underlying the link between NAFLD and HCC...
  39. pmc Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis
    Yasar Colak
    Department of Gastroenterology, Istanbul Medeniyet University, Medical Faculty, Istanbul, Turkey
    Dis Markers 33:77-83. 2012
    ....
  40. doi Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease
    Ebubekir Senates
    Department of Gastroenterology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey
    Metab Syndr Relat Disord 9:287-90. 2011
    ....
  41. doi Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis
    Arzu Tiftikci
    Department of Gastroenterology, Acibadem University School of Medicine, Istanbul, Turkey
    Arch Med Res 40:294-8. 2009
    ..In this study we sought to determine whether serum levels of three adipokines (leptin, adiponectin and resistin) show any biochemical correlation with hepatic steatosis and fibrosis in patients with chronic HCV infection...
  42. ncbi Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry
    Engin Ulukaya
    Department of Biochemistry, Uludag University Medical School, Bursa, Turkey
    Scand J Gastroenterol 44:1471-6. 2009
    ....
  43. doi Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients
    Ozen Oz Gul
    Department of Endocrinology and Metabolism, Uludag University Medical School, Bursa 16059, Turkey
    Metabolism 59:64-9. 2010
    ..We conclude that, in type 2 diabetes mellitus patients, pioglitazone-but not rosiglitazone-significantly raised sRAGE, which may contribute to its antiatherogenic effects...
  44. doi Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Institute of Gastroenterology, Marmara University, Istanbul, Turkey
    Scand J Gastroenterol 47:1488-93. 2012
    ....
  45. ncbi Nonalcoholic fatty liver disease: a nutritional approach
    Yasar Colak
    Department of Gastroenterology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey
    Metab Syndr Relat Disord 10:161-6. 2012
    ..Interestingly, the most common environmental cause of insulin resistance is diet. This article examines the correlations between NAFLD and diet and provides some diet recommendations based on the most current data available...
  46. doi Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease
    Yasar Colak
    Department of Gastroenterology, Istanbul Goztepe Education and Research Hospital, Istanbul, Turkey
    Hepatogastroenterology 58:2087-90. 2011
    ..In this study we assayed plasma levels of fgl2 in patients with biopsy proven non-alcoholic fatty liver disease (NAFLD) and examined their association with clinical, biochemical and histological phenotypes...
  47. ncbi Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
    Yusuf Yilmaz
    Department of Gastroenterology, School of Medicine, Marmara University, Altunizade, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 21:1247-51. 2009
    ....
  48. ncbi Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease
    Mahmut Arabul
    Department of Internal Medicine, Uludag University Medical School, Bursa 16059, Turkey
    Clin Biochem 41:1055-8. 2008
    ..Statins may reduce cardiovascular events in dialysis patients and have pleiotropic effects in addition to lowering total and low-density lipoprotein (LDL)-cholesterol...
  49. pmc Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey
    Gut Liver 8:313-7. 2014
    ..We sought to examine whether the presence of gallstone disease (GD) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) is associated with liver fibrosis and histological nonalcoholic steatohepatitis (NASH) score...
  50. doi Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey Institute of Gastroenterology, Marmara University, Istanbul, Turkey
    Clin Chim Acta 414:154-7. 2012
    ..In this study, we sought to develop a support vector machine (SVM) algorithm to discriminate with high accuracy between subjects with NASH and controls using a blood-based biomarker panel...
  51. pmc Clinical significance of activity of ALT enzyme in patients with hepatitis C virus
    Onder Akkaya
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    World J Gastroenterol 13:5481-5. 2007
    ..To investigate serum alanine aminotransferase (ALT) levels in relation to the clinical, biochemical, ultrasonographic and histological characteristics of patients with hepatitis C virus...
  52. ncbi Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Acta Gastroenterol Belg 75:240-4. 2012
    ....
  53. doi Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis
    Omer Fatih Olmez
    Department of Internal Medicine, Uludag University Medical School, Bursa
    Eur J Gastroenterol Hepatol 22:461-5. 2010
    ..We assessed plasma prohepcidin levels in patients with chronic viral hepatitis and investigated the association of this molecule with iron parameters, histologic activity index, and liver fibrosis scores...
  54. ncbi Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography
    Yusuf Yilmaz
    Departments of aGastroenterology bRadiology, School of Medicine cInstitute of Gastroenterology, Marmara University, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 25:1330-4. 2013
    ..In addition, we sought to investigate the association of CAP with the traditional risk factors for nonalcoholic fatty liver disease in a screening setting...
  55. ncbi Predictive value of the modified Early Warning Score in a Turkish emergency department
    Erol Armagan
    Department of Emergency Medicine, Uludag University Medical School, Bursa, Turkey
    Eur J Emerg Med 15:338-40. 2008
    ..We investigated whether mEWS can predict death, hospital admission, intensive care unit (ICU) admission, and in-hospital deaths in a Turkish setting...
  56. ncbi Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients
    Serkan Torun
    Uludag University Medical School, Department of Internal Medicine, Bursa 16059, Turkey
    World J Gastroenterol 13:6027-30. 2007
    ..To investigate the diagnostic efficacy of leukocyte esterase and nitrite reagent strips for bedside diagnosis of spontaneous bacterial peritonitis (SBP)...
  57. ncbi Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Scand J Gastroenterol 49:611-6. 2014
    ..Herein, we prospectively determined the accuracy of liver fat quantification with CAP values in patients with chronic liver diseases and compare the results with those of histological assessment of steatosis as reference standard...
  58. doi NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Pendik, Istanbul, Turkey
    Semin Liver Dis 32:14-21. 2012
    ..A special focus is given to increased hemoglobin as a risk factor for the development of NAFLD in the absence of MetS...
  59. doi The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy
    Beste M Atasoy
    S B Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Fevzi Cakmak mah Mimar Sinan cad No 41, Ust Kaynarca Pendik, 34899 Istanbul, Turkey
    Eur Arch Otorhinolaryngol 269:275-82. 2012
    ..By providing adequate enteral nutrition the insertion of gastrostomy-tube can increase the completeness rate of concurrent chemotherapy...
  60. ncbi Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease
    Yusuf Yilmaz
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey Institute of Gastroenterology, Marmara University, Istanbul, Turkey Electronic address
    J Diabetes Complications 28:328-31. 2014
    ..In this exploratory study, we sought to investigate the associations of PD and T2D with the severity of the histological features in patients with NAFLD...
  61. ncbi Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials
    Yusuf Yilmaz
    Marmara Universitesi Gastroenteroloji Enstitusu, Karaciger Arastirmalari Birimi, P K 53, Basibuyuk, Maltepe, 34840, Istanbul, Turkey
    Curr Drug Targets 14:1357-66. 2013
    ..The paradigm shift towards an earlier noninvasive characterization and diagnosis of NASH and fibrosis will be crucial to redefine and establish successful interventional trials. ..
  62. doi Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease
    Yusuf Yilmaz
    Institute of Gastroenterology, Marmara University, Maltepe, Istanbul, Turkey
    Clin Chim Acta 413:1190-3. 2012
    ....
  63. doi Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency
    Ramazan Kurt
    Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey
    Arch Med Res 41:369-72. 2010
    ..This study was designed to determine whether folate (5 mg) and vitamin B12 (500 μg) supplementation in elderly patients with vitamin B12 deficiency improved CFR, while reducing homocysteine levels...
  64. doi Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy
    Elif Ari
    Department of Nephrology, Marmara University School of Medicine, Istanbul, Turkey
    Am J Nephrol 33:269-76. 2011
    ..Terlipressin, a long-acting analog of vasopressin, may improve renal function. This study aimed to investigate the possible protective effect of terlipressin against the development of experimental CIN in rats...
  65. doi Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid
    Murat Fazlioglu
    Department of Cardiology, Uludag University School of Medicine, Bursa, Turkey
    Atherosclerosis 202:200-4. 2009
    ..In this study we aimed to evaluate the association of arterial elasticity indexes, serum uric acid and the presence and extent of angiographic coronary artery disease (CAD) in patients with chronic stable angina...
  66. ncbi Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease
    Cagdas Akgullu
    Department of Cardiology, Uludag University Medical School, Bursa, Turkey
    Acta Cardiol 63:467-71. 2008
    ....
  67. doi Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention?
    Cuma Bulent Bulent Gul
    Department of Internal Medicine, Uludag University Medical School, Bursa, 16059 Turkey
    Clin Biochem 41:544-7. 2008
    ..Recently, the value of interleukin (IL)-18 as a novel biomarker for the detection of acute renal failure has been highlighted. In the present study, we sought to investigate whether urine IL-18 may be an early diagnostic marker of CIN...
  68. doi Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia
    Bulent Baran
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    Blood Coagul Fibrinolysis 19:243-6. 2008
    ..Anticardiolipin IgG antibodies were mildly positive. We conclude that the presence of multiple genetic and environmental risk factors greatly amplifies the risk of clinical thrombotic events...
  69. ncbi Apoptosis: why and how does it occur in biology?
    Engin Ulukaya
    Medical School of Uludag University, Medical Biochemistry Department, Bursa, Turkey
    Cell Biochem Funct 29:468-80. 2011
    ..Understanding the molecular mechanisms involved in apoptosis better will make a big impact on human diseases, particularly cancer, and its management in the clinics...
  70. doi Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count
    Elif Ari
    Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey
    Am J Reprod Immunol 62:238-42. 2009
    ..The complement system may play a role in the pathogenesis of this condition. We sought to determine serum complement 3 (C3) levels and its regulatory protein complement factor H (FH) in the HELLP syndrome...
  71. doi Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study
    Ibrahim Akdag
    Department of Nephrology and Rheumatology, Uludag University Medical School, Bursa, Turkey
    Nephron Clin Pract 108:c99-c105. 2008
    ..In this study we sought to investigate the clinical value of the malnutrition-inflammation-atherosclerosis (MIA) syndrome for long-term prediction of cardiovascular mortality in patients treated with ESRD...
  72. ncbi Risk factors for low back pain and its relation with pain related disability and depression in a Turkish sample
    Bulent Tucer
    Erciyes University, School of Medicine, Neurosurgery Department, Kayseri, Turkey
    Turk Neurosurg 19:327-32. 2009
    ..To investigate the relation of depression and pain-related disability associated with Low Back Pain (LBP)...
  73. doi Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori
    Onder Bekar
    Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey
    J Med Food 14:344-7. 2011
    ..We conclude that a 14-day regimen of triple therapy with kefir is more effective in achieving H. pylori eradication than is triple therapy alone...
  74. doi The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease
    Mariella Catalano
    Research Centre on Vascular Diseases, VAS, University of Milan, Luigi Sacco Hospital, Milan, Italy
    Clin Biochem 41:981-5. 2008
    ..The aim of the present study was to clarify whether the Pro12Ala polymorphism of the PPAR-gamma2 gene is related to plasma sRAGE levels and the presence of PAD in nondiabetic Italian individuals...